New drug IDP-001 takes on advanced cancers in early trial
Disease control
Not yet recruiting
This study tests a new drug called IDP-001 in people with advanced or spreading solid tumors, including certain lung, head and neck, and other cancers. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 132 adults who have t…
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC